Clinical phenotype and loss of the slow skeletal muscle troponin T in three new patients with recessive TNNT1 nemaline myopathy.


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
09 2021
Historique:
received: 15 11 2019
revised: 12 06 2020
accepted: 05 07 2020
pubmed: 1 10 2020
medline: 23 2 2022
entrez: 30 9 2020
Statut: ppublish

Résumé

Congenital nemaline myopathies are rare pathologies characterised by muscle weakness and rod-shaped inclusions in the muscle fibres. Using next-generation sequencing, we identified three patients with pathogenic variants in the The clinical phenotype was similar in all patients, associating hypotonia, orthopaedic deformities and progressive chronic respiratory failure, leading to early death. The anatomopathological phenotype was characterised by a disproportion in the muscle fibre size, endomysial fibrosis and nemaline rods. Molecular analyses of The clinical and anatomopathological presentations of our patients reinforce the homogeneous character of the phenotype associated with recessive

Sections du résumé

BACKGROUND
Congenital nemaline myopathies are rare pathologies characterised by muscle weakness and rod-shaped inclusions in the muscle fibres.
METHODS
Using next-generation sequencing, we identified three patients with pathogenic variants in the
RESULTS
The clinical phenotype was similar in all patients, associating hypotonia, orthopaedic deformities and progressive chronic respiratory failure, leading to early death. The anatomopathological phenotype was characterised by a disproportion in the muscle fibre size, endomysial fibrosis and nemaline rods. Molecular analyses of
DISCUSSION
The clinical and anatomopathological presentations of our patients reinforce the homogeneous character of the phenotype associated with recessive

Identifiants

pubmed: 32994279
pii: jmedgenet-2019-106714
doi: 10.1136/jmedgenet-2019-106714
pmc: PMC8394741
doi:

Substances chimiques

Troponin T 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

602-608

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Neuromuscul Dis. 2017;4(2):99-113
pubmed: 28436394
RNA. 2012 Jul;18(7):1319-27
pubmed: 22645380
Muscle Nerve. 2015 May;51(5):767-72
pubmed: 25430424
Rev Neurol (Paris). 2016 Oct;172(10):614-619
pubmed: 27659899
Muscle Nerve. 2016 Apr;53(4):564-9
pubmed: 26296490
Biochemistry. 2016 Aug 16;55(32):4560-7
pubmed: 27429059
Mol Genet Genomic Med. 2017 Nov;5(6):678-691
pubmed: 29178646
Gene. 2016 May 10;582(1):1-13
pubmed: 26774798
Hum Mol Genet. 2018 Sep 15;27(18):3272-3282
pubmed: 29931346
J Muscle Res Cell Motil. 2019 Jun;40(2):111-126
pubmed: 31228046
Am J Hum Genet. 2000 Oct;67(4):814-21
pubmed: 10952871
J Biol Chem. 2005 Apr 8;280(14):13241-9
pubmed: 15665378
J Mol Diagn. 2018 Jul;20(4):533-549
pubmed: 29792937
J Biol Chem. 2003 Jul 11;278(28):26159-65
pubmed: 12732643
Acta Neuropathol Commun. 2019 Jan 5;7(1):3
pubmed: 30611313
Pediatr Neurol. 2014 Aug;51(2):192-7
pubmed: 25079567
Mol Genet Genomic Med. 2014 Mar;2(2):134-7
pubmed: 24689076
Neuromuscul Disord. 2019 Feb;29(2):114-126
pubmed: 30598237
Neuropediatrics. 2007 Dec;38(6):282-6
pubmed: 18461503
J Physiol. 2019 Aug;597(15):3999-4012
pubmed: 31148174

Auteurs

Justine Géraud (J)

Neuropediatric Department, University Hospital Centre Toulouse, Toulouse, France.

Klaus Dieterich (K)

INSERM U1216, Grenoble Alpes University Hospital, Grenoble, France.
INSERM U1037, Cancer Research Center of Toulouse (CRCT), Department of Pathology, Toulouse University Hospital, Toulouse, France.

John Rendu (J)

INSERM U1216, Grenoble Alpes University Hospital, Grenoble, France.
INSERM U1216, University of Grenoble Alpes, Grenoble, France.

Emmanuelle Uro Coste (E)

INSERM U1037, Cancer Research Center of Toulouse (CRCT), Department of Pathology, Toulouse University Hospital, Toulouse, France.

Murielle Dobrzynski (M)

Maternity Department, Brest University Hospital Center, Brest, France.

Pascale Marcorelle (P)

Pathology Department, Brest University Hospital, Morvan Hospital, Brest, France.

Christine Ioos (C)

Neuropediatric Department, Garches University Hospital Center, Garches, France.

Norma Beatriz Romero (NB)

UMRS974, CNRS FRE3617, Center for Research in Myology, INSERM, CNRS, Sorbonne University, UPMC University of Paris 06, Paris, France.
Myology Institute, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.

Eloise Baudou (E)

Neuropediatric Department, University Hospital Centre Toulouse, Toulouse, France.

Julie Brocard (J)

INSERM U1216, Grenoble Alpes University Hospital, Grenoble, France.
INSERM U1216, University of Grenoble Alpes, Grenoble, France.

Anne-Cécile Coville (AC)

Neuropediatric Department, University Hospital Centre Toulouse, Toulouse, France.

Julien Fauré (J)

INSERM U1216, Grenoble Alpes University Hospital, Grenoble, France.
INSERM U1216, University of Grenoble Alpes, Grenoble, France.

Michel Koenig (M)

Molecular Genetics Laboratory, LGMR, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France.

Raul Juntas Morales (R)

Molecular Genetics Laboratory, LGMR, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France.

Emmanuelle Lacène (E)

UMRS974, CNRS FRE3617, Center for Research in Myology, INSERM, CNRS, Sorbonne University, UPMC University of Paris 06, Paris, France.
Myology Institute, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.

Angéline Madelaine (A)

UMRS974, CNRS FRE3617, Center for Research in Myology, INSERM, CNRS, Sorbonne University, UPMC University of Paris 06, Paris, France.
Myology Institute, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.

Isabelle Marty (I)

INSERM U1216, Grenoble Alpes University Hospital, Grenoble, France.
INSERM U1216, University of Grenoble Alpes, Grenoble, France.

Henri Pegeot (H)

Molecular Genetics Laboratory, LGMR, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France.

Corinne Theze (C)

Molecular Genetics Laboratory, LGMR, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France.

Aurore Siegfried (A)

INSERM U1216, University of Grenoble Alpes, Grenoble, France.

Mireille Cossee (M)

Molecular Genetics Laboratory, LGMR, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France.

Claude Cances (C)

Neuropediatric Department, University Hospital Centre Toulouse, Toulouse, France cances.c@chu-toulouse.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH